Given this biological mechanism, it would be expected that maintaining glycemic control would play a particularly important role in preventing CAD in individuals with the Hp2-2 phenotype, as it could potentially reduce Hp2-Hb-induced oxidative damage to blood vessels. The gene discussed is GSTM1; the disease is coronary artery disorder.